Actiza Pharmaceutical Private Limited

Eltrombopag is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura who have failed to respond to corticosteroids, immunoglobulins, or splenectomy. patient.

Eltrombopag should only be used in patients with ITP who have a degree of thrombocytopenia and a clinical condition that increases the risk of bleeding.

Eltrombopag should not be used with the intention of normalizing normal platelet counts. Eltrombopag shows promise in treating aplastic anemia.

Eltrombopag can also be used to treat thrombocytopenia in patients with chronic hepatitis C.

Indications

Treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura.

Itraconazole API is used to treat a number of fungal infections. This includes aspergillosis, blastomycosis, coccidioidomycosis, histoplasmosis, and paracoccidioidomycosis.